Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Frontiers in Bioengineering and Biotechnology
|
October 18, 2023
Quantifying internal intervertebral disc strains to assess nucleus replacement device designs: a digital volume correlation and ultra-high-resolution MRI study
Tamanna Rahman, Saman Tavana, Nicoleta Baxan, et al.
Molecular Oncology
|
December 8, 2015
Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample
Dominic G Rothwell, Nigel Smith, Daniel Morris, et al.
Molecular Oncology
|
December 15, 2015
Development of a circulating miRNA assay to monitor tumor burden: From mouse to man
Alastair Greystoke, Mahmood Ayub, Dominic G Rothwell, et al.
Reproductive Biomedicine Online
|
November 9, 2005
Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line
Anja van de Stolpe, Stieneke van den Brink, Marga van Rooijen, et al.
Human Molecular Genetics
|
April 6, 2007
Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome
Cinzia Allegrucci, Yue-Zhong Wu, Alexandra Thurston, et al.
The Medical Journal of Australia
|
June 17, 2025
Bone health perspectives among Indigenous people: a qualitative study
Troy Walker Yorta Yorta, Karan P Singh, Vanessa Gan, et al.
Journal of the National Cancer Institute
|
October 3, 2002
Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies
Gordon C Jayson, Jamal Zweit, Alan Jackson, et al.
Nature Communications
|
May 21, 2026
Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial
Rebecca J Lee, Dominic G Rothwell, Nigel Smith, et al.
Cancer Chemotherapy and Pharmacology
|
October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours
Laura Horsley, Jeff Cummings, Mark Middleton, et al.
Nature Medicine
|
April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Frontiers in Bioengineering and Biotechnology
|
October 18, 2023
Quantifying internal intervertebral disc strains to assess nucleus replacement device designs: a digital volume correlation and ultra-high-resolution MRI study
Tamanna Rahman, Saman Tavana, Nicoleta Baxan, et al.
Molecular Oncology
|
December 8, 2015
Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample
Dominic G Rothwell, Nigel Smith, Daniel Morris, et al.
Molecular Oncology
|
December 15, 2015
Development of a circulating miRNA assay to monitor tumor burden: From mouse to man
Alastair Greystoke, Mahmood Ayub, Dominic G Rothwell, et al.
Reproductive Biomedicine Online
|
November 9, 2005
Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line
Anja van de Stolpe, Stieneke van den Brink, Marga van Rooijen, et al.
Human Molecular Genetics
|
April 6, 2007
Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome
Cinzia Allegrucci, Yue-Zhong Wu, Alexandra Thurston, et al.
The Medical Journal of Australia
|
June 17, 2025
Bone health perspectives among Indigenous people: a qualitative study
Troy Walker Yorta Yorta, Karan P Singh, Vanessa Gan, et al.
Journal of the National Cancer Institute
|
October 3, 2002
Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies
Gordon C Jayson, Jamal Zweit, Alan Jackson, et al.
Nature Communications
|
May 21, 2026
Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial
Rebecca J Lee, Dominic G Rothwell, Nigel Smith, et al.
Cancer Chemotherapy and Pharmacology
|
October 22, 2013
A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours
Laura Horsley, Jeff Cummings, Mark Middleton, et al.
Nature Medicine
|
April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.
Page
of 4